Acorn Biolabs
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
CAD3.4m | Seed | ||
* | N/A | Series A | |
* | CAD11.0m | Series A | |
Total Funding | €9.6m |
Recent News about Acorn Biolabs
EditAcorn Biolabs specializes in the collection and storage of stem cells, making regenerative medicine accessible and affordable. The company operates in the healthcare market, focusing on individuals who wish to preserve their younger, healthier cells for future medical use. Acorn Biolabs employs a non-invasive method to collect cells, typically from hair follicles, which are then stored for potential future applications in personalized healthcare and advanced analytics. The business model revolves around a subscription-based service where clients pay for the initial collection and ongoing storage of their cells. Revenue is generated through these subscription fees, as well as potential future services related to the use of stored cells in medical treatments. Acorn Biolabs aims to provide peace of mind by ensuring that clients have a viable healthcare resource available as they age, addressing the growing demand for personalized and regenerative medicine solutions.
Keywords: stem cells, regenerative medicine, cell storage, non-invasive collection, personalized healthcare, advanced analytics, subscription service, healthcare resource, future medical use, accessible treatment.